急性ST段抬高型心肌梗死急诊介入治疗的预后因素研究进展  

Research Progress in Prognostic Factors of Emergency Interventional Therapy for Acute ST Segment Elevation Myocardial Infarction

作　　者：艾力夏提·阿地力 陈铀[1] 

机构地区：[1]新疆医科大学第一附属医院冠心病一科,新疆 乌鲁木齐

出　　处：《临床医学进展》2024年第1期240-246,共7页Advances in Clinical Medicine

摘　　要：急性ST段抬高型心肌梗死(Acute ST segment elevation myocardial infarction, ASTEMI)是冠状动脉病变导致心脏血供急剧减少或中断,使相应的心肌持续性缺血并严重受损的一种心脏疾病。急诊经皮冠状动脉介入(Emergency percutaneous coronary intervention, ECPCI)治疗是目前广泛使用的ASTEMI有效治疗手段之一,其预后因素的最新研究进展受到广泛关注。现对近年来急性ST段抬高型心肌梗死急诊介入治疗的预后因素研究进展进行综述。Acute ST segment elevation myocardial infarction (ASTEMI) is a heart disease in which coronary artery disease leads to a sharp decrease or interruption of the heart’s blood supply, resulting in continuous myocardial ischemia and severe damage. Emergency percutaneous coronary interven-tion (ECPCI) is one of the most widely used effective ASTEMI therapies, and recent advances in prognostic factors have attracted widespread attention. Recent advances in prognostic factors of emergency interventional therapy for acute ST segment elevation myocardial infarction are re-viewed.

关 键 词：急性ST段抬高型心肌梗死 急诊介入治疗 预后因素研究进展 

分 类 号：R54[医药卫生—心血管疾病]